Company / SG&A per Share
NeoGenomics Laboratories, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.13
FY2025
5-year range
$1.85 / $2.13
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#111 of 156
Health Care
What the data says
At $2.13, NeoGenomics Laboratories, Inc.'s sg&a per share ranks #46 of 156 in the Health Care sector. Increased from $1.94 to $2.13 over the past 2 years.
Based on SEC 10-K filings.
2.13 in FY2025 with a 5-year CAGR of +10.7%.
Increased from $1.94 to $2.13 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.9%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Sector benchmark
#46 of 156 in Health CareTop 29% of 156This company $2.13 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 4.1% year-over-year.
- Ranks #111 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.13 | +4.1% |
| FY2024 | $2.05 | +5.9% |
| FY2023 | $1.94 | -1.1% |
| FY2022 | $1.96 | +6.2% |
| FY2021 | $1.85 | +43.5% |
| FY2020 | $1.29 | +4.1% |
| FY2019 | $1.24 | +33.4% |
| FY2018 | $0.93 | +3.4% |
| FY2017 | $0.90 | +6.2% |
| FY2016 | $0.84 | +51.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026